British & American Investment Trust : Reporting Dpcument
June 29, 2022 at 07:38 am
Share
BRITISH & AMERICAN INVESTMENT TRUST PLC
29 JUNE 2022
Annual General Meeting on 28 JUNE 2022
British & American Investment Trust PLC announces that, at the Annual General Meeting held on Tuesday, all eight resolutions proposed were duly passed.
The full text of the resolutions can be found in the Notice of Annual General Meeting set out on page 70 of the Report & Accounts for the year ended 31 December 2021, copies of which have been submitted to the National Storage Mechanism, and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The results of the polls are as follows:
Resolution
Receiving the report and accounts
Re-electionof Mr DG Seligman as a director
Re-electionof Mr A Tamlyn as a director
Re-electionof Mr JC Woolf as a director
Election of Ms J Le Blan as a director
Approval of the directors' remuneration report (excluding policy)
7. Appointment of Hazlewoods LLP as the company's auditors
8. Authority to determine the remuneration of the auditors
For
Against
Votes
withheld
17,105,559
nil
nil
17,094,559
11,000
nil
17,094,559
11,000
nil
17,095,559
10,000
nil
17,105,559
nil
nil
17,077,708
27,851
nil
17,105,559
nil
nil
17,104,559
1,000
nil
On 28 June 2022 there were 25,000,000 relevant shares in issue. Shareholders are entitled to one vote per share. Votes withheld are not votes and, therefore, have not been counted in the calculation of the proportion of votes for and against a resolution.
For further information please contact:
Keith Williams
Secretary
British & American Investment Trust PLC
Tel: 020 7201 3100
Attachments
Original Link
Original Document
Permalink
Disclaimer
British and American Investment Trust plc published this content on 29 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 June 2022 11:37:02 UTC.
British & American Investment Trust PLC is a self-managed investment trust company. The Company invests in investment trusts and other United Kingdom and United States-quoted companies. The Companyâs investment portfolio includes Lineage Cell Therapeutics (USA), Dunedin Income Growth, Geron Corporation (USA), Aberdeen Diversified Income & Growth, Relief Therapeutics (Switzerland), AgeX (USA), Audioboom Group, ADVFN, Braemar Shipping Services and Electra Private Equity. The Company's invests sectors include biotechnology, investment trust, biomedical, healthcare, media, semiconductors and telecommunications.